Janux Therapeutics Statistics
NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.08-0.21 (-2.04%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Janux Therapeutics by the numbers
Janux Therapeutics has a market capitalization of $616.7 million based on 61.18M shares outstanding. With trailing EPS of $-1.59, Janux Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.8% below its 50-day average and 34.1% below its 200-day average.
Average daily trading volume is 961.56K shares, or about $9.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
JANX valuation vs. peer median
| Metric | JANX | Peer median | Difference |
|---|---|---|---|
| Market cap | $616.73M | $615.62M | +0% |
| Avg. volume | 961.56K | 1.36M | -29% |
Peer median across 8 companies: ABUS, OLMA, KURA, ANNX, SGMT, IMMX, DSGN, NVCT.
Valuation
- Market cap
- $616.73M
- Price / sales (latest FY)
- 61.67
- EPS (TTM)
- $-1.59
- Shares outstanding
- 61.18M
Price and trading
- Previous close
- 10.29
- Open
- 10.16
- Day range
- 10.05 – 10.54
- 52-week range
- 10.05 – 35.34
- 52-week change
- -65.00%
- Beta
- —
- Volume
- 1.11M
- Average volume
- 961.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 616.73M
- Forward Pe
- -3.95
- Eps
- -1.59
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 35.34
- Week52 Low
- 10.05
- Avg Volume
- 961.56K
- Shares Outstanding
- 61.18M
- Ma50
- 15.96
- Ma200
- 15.28
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -71.48%
- Pct From52w Low
- 0.30%